OpenAI, PerturbAI and Scripps Research use thousands of GPT-Rosalind agents on brain CRISPR data

OpenAI reports that, with PerturbAI and Scripps Research, thousands of AI agents powered by GPT-Rosalind analysed existing experimental data from millions of mouse brain cells in 32 minutes, linking gene-disruption effects to the literature to surface leads on Alzheimer's and Parkinson's biology (post dated October 21, 2026). The leads are hypotheses from the authors' own analysis.